Facebooktwittergoogle_plusredditlinkedintumblrmail

With automation and globalization come a variety of issues that affect manufacturing decisions concerning standardization, certification, and regulatory validation. The biopharmaceutical industry faces challenges related to the automation process’s unseen operational costs.

Read article